Clinical Trial Update: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia. [Phase 4]

View source ↗

Summary

Phase 4 crossover trial comparing NeoRecormon (epoetin beta) and darbepoetin alfa in patients with anemia due to chronic kidney disease to evaluate relative eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• NeoRecormon (epoetin beta)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED